SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (1973)7/13/1998 12:06:00 PM
From: Exacctnt  Read Replies (2) | Respond to of 2553
 
Bob, I'm also watching CNBC. I picked up some ATIS for pure speculation in the event that comments are positive for that company. It's low enough already from their problems at their manufacturing site.

Already have enough GENZL.

Let's hope their some interest.

Regards,
Bob



To: Machaon who wrote (1973)7/13/1998 12:10:00 PM
From: Exacctnt  Respond to of 2553
 
Bob, The story hasn't aired yet, but both GENZL and ATIS volume is picking up nicely.

Regards,
Bob



To: Machaon who wrote (1973)7/13/1998 1:02:00 PM
From: Linda Kaplan  Respond to of 2553
 
Yes, I was just going to post. Now if CNBC would PLEASE mention GENZL instead of GENZ. Please, please...

Linda


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News